The PolyNovo (ASX:PNV) share price is up 30% in November

The PolyNovo Ltd (ASX:PNV) share price has been on fire in November and is up 30% since the start of the month…

| More on:
ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

The PolyNovo Ltd (ASX: PNV) share price has continued its positive run on Monday.

In afternoon trade the medical device company's shares are up over 4% to $3.22.

This leaves the PolyNovo share price trading just short of its record high of $3.28. It also means the company's shares are now up 30% since this time last month.

Why is the PolyNovo share price rocketing higher this month?

There have been a number of catalysts for the strong gain by the PolyNovo share price this month.

The first is of course the development of three potentially effective COVID-19 vaccines. This has given investor sentiment a huge boost and sent global share markets charging higher.

In addition to this. a couple of company-specific announcements have gone down well with investors and given the PolyNovo share price a lift.

What did PolyNovo announce?

On November 13, PolyNovo announced that the United States Food and Drug Administration (FDA) has approved the pivotal trial IDE for NovoSorb BTM.

This authorisation allows the company to begin patient recruitment, once various hospital Independent Review Boards grant approval. This relates to its treatment of full thickness burns.

Management is now seeking to utilise 20 sites and enlist 150 patients for the clinical study of NovoSorb BTM.

Recruitment is expected to start in early 2021 and conclude around the end of 2023. This program is being supported by Biomedical Advanced Research and Development Authority (BARDA) funding of $150 million.

In addition to this, another announcement on 19 November gave the PolyNovo share price a boost.

That announcement revealed its entry into Belgium, Netherlands, Luxemburg (Benelux), and Sweden through an extension of its partnership with PolyMedics Innovations in Germany.

Management notes that PMI has been an excellent partner for it in Germany, Switzerland, and Austria. Sales in these markets are exceeding projections to date and showing signs of further growth.

PolyNovo's Managing Director, Paul Brennan, was happy with the news. He said: "We are very pleased to extend our partnership with PMI. They are an excellent sales organisation with very good relationships with surgeons not only in DACH (Germany, Austria, Switzerland) but also in Sweden, Belgium and the Netherlands."

Shareholders will no doubt be hoping December is just as kind to the PolyNovo share price. Time will tell!

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors were nervous this Friday, ending the week on a sour note.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Share Gainers

Why EOS, Evolution Mining, Renascor, and Woodside shares are jumping today

These shares are ending the week on a high. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a volatile, but negative day for ASX investors this Thursday.

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Share Gainers

Guess which ASX 200 stock turned $5,000 into $34,264 in just three years!

Investors have been piling into this ASX 200 stock for years, sending the share price soaring.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why Beach Energy, Meeka Metals, Monash IVF, and Qantas shares are racing higher today

These shares are having a better day than most on Thursday. But why?

Read more »

Rising gold share price represented by a green arrow on piles of gold block.
Share Gainers

2 ASX All Ords stocks that would already have more than doubled your money this year

These ASX All Ords stocks have gained 126% and 145% year to date. But how?

Read more »

Ten smiling business people wave to the camera after receiving some winning company news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was an historic day for the ASX, with the market setting a new record.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Fletcher Building, Johns Lyng, Pilbara Minerals, and Zip shares are charging higher

These shares are having a strong session on hump day. But why?

Read more »